{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T15:12:42Z","timestamp":1742915562265,"version":"3.40.3"},"publisher-location":"Cham","reference-count":107,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030740450"},{"type":"electronic","value":"9783030740467"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-74046-7_9","type":"book-chapter","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T18:02:39Z","timestamp":1630087359000},"page":"119-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rita Levi-Montalcini, NGF Metabolism in Health and in the Alzheimer\u2019s Pathology"],"prefix":"10.1007","author":[{"given":"A. Claudio","family":"Cuello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1523\/JNEUROSCI.1144-11.2012","volume":"32","author":"S Allard","year":"2012","unstructured":"Allard S, Leon WC, Pakavathkumar P, Bruno MA, Ribeiro-Da-Silva A, Cuello AC (2012) Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J Neurosci 32:2002\u20132012","journal-title":"J Neurosci"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2018.03.002","volume":"67","author":"S Allard","year":"2018","unstructured":"Allard S, Jacobs ML, Do Carmo S, Cuello AC (2018) Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons. Neurobiol Aging 67:10\u201320","journal-title":"Neurobiol Aging"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tcb.2004.05.011","volume":"14","author":"L Aloe","year":"2004","unstructured":"Aloe L (2004) Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology. Trends Cell Biol 14:395\u2013399","journal-title":"Trends Cell Biol"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL 3rd, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408\u2013414","journal-title":"Science"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/mcne.1996.0014","volume":"7","author":"A Blochl","year":"1996","unstructured":"Blochl A, Thoenen H (1996) Localization of cellular storage compartments and sites of constitutive and activity-dependent release of nerve growth factor (NGF) in primary cultures of hippocampal neurons. Mol Cell Neurosci 7:173\u2013190","journal-title":"Mol Cell Neurosci"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/brain\/99.3.459","volume":"99","author":"DM Bowen","year":"1976","unstructured":"Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459\u2013496","journal-title":"Brain"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1073\/pnas.0510645103","volume":"103","author":"MA Bruno","year":"2006","unstructured":"Bruno MA, Cuello AC (2006) Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci U S A 103:6735\u20136740","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","volume":"68","author":"MA Bruno","year":"2009","unstructured":"Bruno MA, Leon WC, Fragoso G, Mushynski WE, Almazan G, Cuello AC (2009a) Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease. J Neuropathol Exp Neurol 68:857\u2013869","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/NEN.0b013e3181c22569","volume":"68","author":"MA Bruno","year":"2009","unstructured":"Bruno MA, Mufson EJ, Wuu J, Cuello AC (2009b) Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 68:1309\u20131318","journal-title":"J Neuropathol Exp Neurol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/mus.880020510","volume":"2","author":"M Caccia","year":"1979","unstructured":"Caccia M, Meola G, Cerri C, Frattola L, Scarlato G, Aporti FJM (1979) Treatment of denervated muscle by gangliosides. Muscle Nerve 2:382\u2013389","journal-title":"Muscle Nerve"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-1-4614-4614-9_17","volume":"71","author":"B Ceccarelli","year":"1976","unstructured":"Ceccarelli B, Aporti F, Finesso M (1976) Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation. Adv Exp Med Biol 71:275\u2013293","journal-title":"Adv Exp Med Biol"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, Delong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Science 219:1184\u20131190","journal-title":"Science"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1054-3589(08)60338-5","volume":"21","author":"AC Cuello","year":"1990","unstructured":"Cuello AC (1990) Glycosphingolipids that can regulate nerve growth and repair. Adv Pharmacol 21:1\u201350","journal-title":"Adv Pharmacol"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s11064-012-0770-9","volume":"37","author":"AC Cuello","year":"2012","unstructured":"Cuello AC (2012) Gangliosides, NGF, brain aging and disease: a mini-review with personal reflections. Neurochem Res 37:1256\u20131260","journal-title":"Neurochem Res"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0166-2236(84)80161-7","volume":"7","author":"AC Cuello","year":"1984","unstructured":"Cuello AC, Sofroniew MV (1984) The anatomy of the CNS cholinergic neurons. Trends Neurosci 7:74\u201378","journal-title":"Trends Neurosci"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0006-8993(86)90202-7","volume":"376","author":"AC Cuello","year":"1986","unstructured":"Cuello AC, Stephens PH, Tagari PC, Sofroniew MV, Pearson RC (1986) Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1. Brain Res 376:373\u2013377","journal-title":"Brain Res"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1073\/pnas.86.6.2056","volume":"86","author":"AC Cuello","year":"1989","unstructured":"Cuello AC, Garofalo L, Kenigsberg RL, Maysinger D (1989) Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci U S A 86:2056\u20132060","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnins.2019.00062","volume":"13","author":"AC Cuello","year":"2019","unstructured":"Cuello AC, Pentz R, Hall H (2019) The brain NGF metabolic pathway in health and in Alzheimer\u2019s pathology. Front Neurosci 13:62","journal-title":"Front Neurosci"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet 2:1403","journal-title":"Lancet"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1073\/pnas.96.7.4067","volume":"96","author":"T Debeir","year":"1999","unstructured":"Debeir T, Saragovi HU, Cuello AC (1999) A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci U S A 96:4067\u20134072","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/194794a0","volume":"194","author":"E De Robertis","year":"1962","unstructured":"De Robertis E, De Lores Arnaiz GR, De Iraldi AP (1962) Isolation of synaptic vesicles from nerve endings of the rat brain. Nature 194:794\u2013795","journal-title":"Nature"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","volume":"30","author":"DA Drachman","year":"1974","unstructured":"Drachman DA, Leavitt J (1974) Human memory and the cholinergic system. A relationship to aging? Arch Neurol 30:113\u2013121","journal-title":"Arch Neurol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0306-4522(89)90030-4","volume":"31","author":"PJ Elliott","year":"1989","unstructured":"Elliott PJ, Garofalo L, Cuello AC (1989) Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity\u2014effects of the monosialoganglioside GM1. Neuroscience 31:63\u201376","journal-title":"Neuroscience"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0169-328X(96)00193-3","volume":"42","author":"M Fahnestock","year":"1996","unstructured":"Fahnestock M, Scott SA, Jette N, Weingartner JA, Crutcher KA (1996) Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer\u2019s disease parietal cortex. Brain Res Mol Brain Res 42:175\u2013178","journal-title":"Brain Res Mol Brain Res"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1006\/mcne.2001.1016","volume":"18","author":"M Fahnestock","year":"2001","unstructured":"Fahnestock M, Michalski B, Xu B, Coughlin MD (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer\u2019s disease. Mol Cell Neurosci 18:210\u2013220","journal-title":"Mol Cell Neurosci"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1471-4159.2004.02360.x","volume":"89","author":"M Fahnestock","year":"2004","unstructured":"Fahnestock M, Yu G, Michalski B, Mathew S, Colquhoun A, Ross GM, Coughlin MD (2004) The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J Neurochem 89:581\u2013592","journal-title":"J Neurochem"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1046\/j.1471-4159.1997.68062348.x","volume":"68","author":"T Farooqui","year":"1997","unstructured":"Farooqui T, Franklin T, Pearl DK, Yates AJ (1997) Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA. J Neurochem 68:2348\u20132355","journal-title":"J Neurochem"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3233\/JAD-141068","volume":"43","author":"D Ferreira","year":"2015","unstructured":"Ferreira D, Westman E, Eyjolfsdottir H, Almqvist P, Lind G, Linderoth B, Seiger A, Blennow K, Karami A, Darreh-Shori T, Wiberg M, Simmons A, Wahlund LO, Wahlberg L, Eriksdotter M (2015) Brain changes in Alzheimer\u2019s disease patients with implanted encapsulated cells releasing nerve growth factor. J Alzheimers Dis 43:1059\u20131072","journal-title":"J Alzheimers Dis"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0306-4522(95)91510-J","volume":"68","author":"BC Figueiredo","year":"1995","unstructured":"Figueiredo BC, Skup M, Bedard AM, Tetzlaff W, Cuello AC (1995) Differential expression of p140trk, p75NGFR and growth-associated phosphoprotein-43 genes in nucleus basalis magnocellularis, thalamus and adjacent cortex following neocortical infarction and nerve growth factor treatment. Neuroscience 68:29\u201345","journal-title":"Neuroscience"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/cne.902690112","volume":"269","author":"FH Gage","year":"1988","unstructured":"Gage FH, Armstrong DM, Williams LR, Varon S (1988) Morphological response of axotomized septal neurons to nerve growth factor. J Comp Neurol 269:147\u2013155","journal-title":"J Comp Neurol"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/exnr.1994.1024","volume":"125","author":"L Garofalo","year":"1994","unstructured":"Garofalo L, Cuello AC (1994) Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Exp Neurol 125:195\u2013217","journal-title":"Exp Neurol"},{"key":"9_CR32","first-page":"527","volume":"272","author":"L Garofalo","year":"1995","unstructured":"Garofalo L, Cuello AC (1995) Pharmacological characterization of nerve growth factor and\/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. J Pharmacol Exp Ther 272:527\u2013545","journal-title":"J Pharmacol Exp Ther"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1073\/pnas.89.7.2639","volume":"89","author":"L Garofalo","year":"1992","unstructured":"Garofalo L, Ribeiro-Da-Silva A, Cuello AC (1992) Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals. Proc Natl Acad Sci U S A 89:2639\u20132643","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0306-4522(93)90109-S","volume":"57","author":"L Garofalo","year":"1993","unstructured":"Garofalo L, Ribeiro-Da-Silva A, Cuello AC (1993) Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1. Neuroscience 57:21\u201340","journal-title":"Neuroscience"},{"key":"9_CR35","first-page":"85","volume":"387","author":"M Goedert","year":"1986","unstructured":"Goedert M, Fine A, Hunt SP, Ullrich A (1986) Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer\u2019s disease. Brain Res 387:85\u201392","journal-title":"Brain Res"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0006-8993(80)90451-5","volume":"197","author":"A Gorio","year":"1980","unstructured":"Gorio A, Carmignoto G, Facci L, Finesso M (1980) Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth. Brain Res 197:236\u2013241","journal-title":"Brain Res"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0306-4522(83)90188-4","volume":"8","author":"A Gorio","year":"1983","unstructured":"Gorio A, Carmignoto G, Finesso M, Polato P, Nunzi MG (1983a) Muscle reinnervation\u2014II. Sprouting, synapse formation and repression. Neuroscience 8:403\u2013IN1","journal-title":"Neuroscience"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0306-4522(83)90189-6","volume":"8","author":"A Gorio","year":"1983","unstructured":"Gorio A, Marini P, Zanoni R (1983b) Muscle reinnervation\u2014III. Motoneuron sprouting capacity, enhancement by exogenous gangliosides. Neuroscience 8:417\u2013429","journal-title":"Neuroscience"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000110265","volume":"10","author":"E Granieri","year":"1991","unstructured":"Granieri E, Casetta I, Govoni V, Tola MR, Paolino E, Rocca WA (1991) Ganglioside therapy and Guillain-Barre syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association. Neuroepidemiology 10:161\u2013169","journal-title":"Neuroepidemiology"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1523\/JNEUROSCI.16-24-07950.1996","volume":"16","author":"ML Grimes","year":"1996","unstructured":"Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, Valletta JS, Topp KS, Lavail JH, Bunnett NW, Mobley WC (1996) Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes. J Neurosci 16:7950\u20137964","journal-title":"J Neurosci"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jez.1401110308","volume":"111","author":"V Hamburger","year":"1949","unstructured":"Hamburger V, Levi-Montalcini R (1949) Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 111:457\u2013501","journal-title":"J Exp Zool"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933","journal-title":"Brain"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/bst0170075","volume":"17","author":"JA Hardy","year":"1989","unstructured":"Hardy JA, Owen MJ, Goate AM, James LA, Haynes AR, Rossor MN, Roques P, Mullan MJ (1989) Molecular genetics of Alzheimer\u2019s disease. Biochem Soc Trans 17:75\u201376","journal-title":"Biochem Soc Trans"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1567205012666151020114607","volume":"13","author":"E Head","year":"2016","unstructured":"Head E, Lott IT, Wilcock DM, Lemere CA (2016) Aging in Down syndrome and the development of Alzheimer\u2019s disease neuropathology. Curr Alzheimer Res 13:18\u201329","journal-title":"Curr Alzheimer Res"},{"key":"9_CR45","volume-title":"The organization of behavior: a neuropsychological theory","author":"DO Hebb","year":"1949","unstructured":"Hebb DO (1949) The organization of behavior: a neuropsychological theory. Wiley, Chapman & Hall, New York"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1523\/JNEUROSCI.06-08-02155.1986","volume":"6","author":"F Hefti","year":"1986","unstructured":"Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155\u20132162","journal-title":"J Neurosci"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/ana.410200302","volume":"20","author":"F Hefti","year":"1986","unstructured":"Hefti F, Weiner WJ (1986) Nerve growth factor and Alzheimer\u2019s disease. Ann Neurol 20:275\u2013281","journal-title":"Ann Neurol"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0006-8993(74)90536-8","volume":"68","author":"IA Hendry","year":"1974","unstructured":"Hendry IA, St\u00f6ckel K, Thoenen H, Iversen LL (1974) The retrograde axonal transport of nerve growth factor. Brain Res 68:103\u2013121","journal-title":"Brain Res"},{"issue":"2","key":"9_CR502","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3940(98)00019-6","volume":"241","author":"C Hock","year":"1998","unstructured":"Hock C, Heese K, M\u00fcller-Spahn F, Hulette C, Rosenberg C, Otten U (1998) Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer\u2019s disease. Neurosci Lett 241(2):151\u2013154. https:\/\/doi.org\/10.1016\/S0304-3940(98)00019-6","journal-title":"Neurosci Lett"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1046\/j.1460-9568.2000.00190.x","volume":"12","author":"MC Hoener","year":"2000","unstructured":"Hoener MC (2000) Role played by sodium in activity-dependent secretion of neurotrophins\u2014revisited. Eur J Neurosci 12:3096\u20133106","journal-title":"Eur J Neurosci"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","volume":"76","author":"RM Holsinger","year":"2000","unstructured":"Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M (2000) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer\u2019s disease. Brain Res Mol Brain Res 76:347\u2013354","journal-title":"Brain Res Mol Brain Res"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tips.2014.04.010","volume":"35","author":"MF Iulita","year":"2014","unstructured":"Iulita MF, Cuello AC (2014) Nerve growth factor metabolic dysfunction in Alzheimer\u2019s disease and Down syndrome. Trends Pharmacol Sci 35:338\u2013348","journal-title":"Trends Pharmacol Sci"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1567205012666150921100030","volume":"13","author":"MF Iulita","year":"2016","unstructured":"Iulita MF, Cuello AC (2016) The NGF metabolic pathway in the CNS and its dysregulation in down syndrome and Alzheimer\u2019s disease. Curr Alzheimer Res 13:53\u201367","journal-title":"Curr Alzheimer Res"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/brain\/awt372","volume":"137","author":"MF Iulita","year":"2014","unstructured":"Iulita MF, Do Carmo S, Ower AK, Fortress AM, Flores Aguilar L, Hanna M, Wisniewski T, Granholm A-C, Buhusi M, Busciglio J, Cuello AC (2014) Nerve growth factor metabolic dysfunction in Down\u2019s syndrome brains. Brain 137:860\u2013872","journal-title":"Brain"},{"key":"9_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1871527315666160321104916","volume":"15","author":"MF Iulita","year":"2016","unstructured":"Iulita MF, Caraci F, Cuello AC (2016a) A link between nerve growth factor metabolic deregulation and amyloid-beta-driven inflammation in Down syndrome. CNS Neurol Disord Drug Targets 15:434\u2013447","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jalz.2016.05.001","volume":"12","author":"MF Iulita","year":"2016","unstructured":"Iulita MF, Ower A, Barone C, Pentz R, Gubert P, Romano C, Cantarella RA, Elia F, Buono S, Recupero M, Romano C, Castellano S, Bosco P, DI Nuovo S, Drago F, Caraci F, Cuello AC (2016b) An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: relation to cognitive decline and longitudinal evaluation. Alzheimers Dement 12:1132\u20131148","journal-title":"Alzheimers Dement"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nbd.2017.08.019","volume":"108","author":"MF Iulita","year":"2017","unstructured":"Iulita MF, Bistue Millon MB, Pentz R, Aguilar LF, Do Carmo S, Allard S, Michalski B, Wilson EN, Ducatenzeiler A, Bruno MA, Fahnestock M, Cuello AC (2017) Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer\u2019s disease. Neurobiol Dis 108:307\u2013323","journal-title":"Neurobiol Dis"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0169-328X(94)90159-7","volume":"25","author":"N Jette","year":"1994","unstructured":"Jette N, Cole MS, Fahnestock M (1994) NGF mRNA is not decreased in frontal cortex from Alzheimer\u2019s disease patients. Brain Res Mol Brain Res 25:242\u2013250","journal-title":"Brain Res Mol Brain Res"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jalz.2014.11.008","volume":"11","author":"A Karami","year":"2015","unstructured":"Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger A, Nordberg A, Wahlberg L, DARREH-Shori T, Eriksdotter M (2015) Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer\u2019s disease. Alzheimers Dement 11:1316\u20131328","journal-title":"Alzheimers Dement"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0197-4580(89)80013-2","volume":"10","author":"JH Kordower","year":"1989","unstructured":"Kordower JH, Gash DM, Bothwell M, Hersh L, Mufson EJ (1989) Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer\u2019s patients. Neurobiol Aging 10:67\u201374","journal-title":"Neurobiol Aging"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1126\/science.3798108","volume":"235","author":"LF Kromer","year":"1987","unstructured":"Kromer LF (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214\u2013216","journal-title":"Science"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/bmj.308.6944.1638a","volume":"308","author":"G Landi","year":"1994","unstructured":"Landi G, Ciccone A, D\u2019alessandro R, Dossi BC, Ricci S, Simone IL (1994) Gangliosides and the Guillain-Barre syndrome. BMJ 308:1638","journal-title":"BMJ"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jnr.490120204","volume":"12","author":"RW Ledeen","year":"1984","unstructured":"Ledeen RW (1984) Biology of gangliosides: neuritogenic and neuronotrophic properties. J Neurosci Res 12:147\u2013159","journal-title":"J Neurosci Res"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0076-6879(82)83012-7","volume":"83","author":"RW Ledeen","year":"1982","unstructured":"Ledeen RW, Yu RK (1982) Gangliosides: structure, isolation, and analysis. Methods Enzymol 83:139\u2013191","journal-title":"Methods Enzymol"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.143.3602.105","volume":"143","author":"R Levi-Montalcini","year":"1964","unstructured":"Levi-Montalcini R (1964) Growth control of nerve cells by a protein factor and its antiserum: discovery of this factor may provide new leads to understanding of some neurogenetic processes. Science 143:105\u2013110","journal-title":"Science"},{"key":"9_CR65","volume-title":"In praise of imperfection : my life and work","author":"R Levi-Montalcini","year":"1988","unstructured":"Levi-Montalcini R (1988) In praise of imperfection : my life and work. Basic Books, New York"},{"key":"9_CR66","doi-asserted-by":"crossref","unstructured":"Levi-Montalcini R (1997) Les cons\u00e9quences de la destruction d\u2019un territoire d\u2019innervation p\u00e9riph\u00e9rique sur le d\u00e9veloppement des centres nerveux correspondants dans l\u2019embryon de poulet. In: The Saga of the nerve growth factor: preliminary studies, discovery, further development. World Scientific","DOI":"10.1142\/9789812830319_0001"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1073\/pnas.82.20.7111","volume":"82","author":"R Levi-Montalcini","year":"1985","unstructured":"Levi-Montalcini R, Aloe L (1985) Differentiating effects of murine nerve growth factor in the peripheral and central nervous systems of Xenopus laevis tadpoles. Proc Natl Acad Sci U S A 82:7111\u20137115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF01738910","volume":"189","author":"O Loewi","year":"1921","unstructured":"Loewi O (1921) \u00dcber humorale \u00fcbertragbarkeit der Herznervenwirkung. Pfl\u00fcger\u2019s Archiv f\u00fcr die gesamte Physiologie des Menschen und der Tiere 189:239\u2013242","journal-title":"Pfl\u00fcger\u2019s Archiv f\u00fcr die gesamte Physiologie des Menschen und der Tiere"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.1982.tb26840.x","volume":"396","author":"IT Lott","year":"1982","unstructured":"Lott IT (1982) Down\u2019s syndrome, aging, and Alzheimer\u2019s disease: a clinical review. Ann N Y Acad Sci 396:15\u201327","journal-title":"Ann N Y Acad Sci"},{"key":"9_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E (2019) Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol 15:135\u2013147","journal-title":"Nat Rev Neurol"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0006-8993(88)90267-3","volume":"461","author":"D Maysinger","year":"1988","unstructured":"Maysinger D, Herrera-Marschitz M, Carlsson A, Garofalo L, Cuello AC, Ungerstedt U (1988) Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: effects of treatment with monosialoganglioside GM1. Brain Res 461:355\u2013360","journal-title":"Brain Res"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0028-3908(90)90055-V","volume":"29","author":"D Maysinger","year":"1990","unstructured":"Maysinger D, Herrera-Marschitz M, Ungerstedt U, Cuello AC (1990a) Acetylcholine release in vivo: effects of chronic treatment with monosialoganglioside GM1. Neuropharmacology 29:151\u2013159","journal-title":"Neuropharmacology"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0304-3940(90)90640-U","volume":"118","author":"D Maysinger","year":"1990","unstructured":"Maysinger D, Herrera-Marschitz M, Ungerstedt U, Cuello AC (1990b) Effects of treatment with microencapsulated monosialoganglioside GM1 on cortical and striatal acetylcholine release in rats with cortical devascularizing lesions. Neurosci Lett 118:252\u2013256","journal-title":"Neurosci Lett"},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/0006-8993(92)90287-J","volume":"577","author":"D Maysinger","year":"1992","unstructured":"Maysinger D, Herrera-Marschitz M, Goiny M, Ungerstedt U, Claudio Cuello, A. (1992) Effects of nerve growth factor on cortical and striatal acetylcholine and dopamine release in rats with cortical devascularizing lesions. Brain Research 577:300\u2013305","journal-title":"Brain Research"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0169-328X(86)90020-3","volume":"1","author":"WC Mobley","year":"1986","unstructured":"Mobley WC, Rutkowski JL, Tennekoon GI, Gemski J, Buchanan K, Johnston MV (1986) Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Mol Brain Res 1:53\u201362","journal-title":"Mol Brain Res"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1046\/j.1460-9568.1998.00314.x","volume":"10","author":"M Molnar","year":"1998","unstructured":"Molnar M, Tongiorgi E, Avignone E, Gonfloni S, Ruberti F, Domenici L, Cattaneo A (1998) The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible. Eur J Neurosci 10:3127\u20133140","journal-title":"Eur J Neurosci"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1523\/JNEUROSCI.19-06-02069.1999","volume":"19","author":"SJ Mowla","year":"1999","unstructured":"Mowla SJ, Pareek S, Farhadi HF, Petrecca K, Fawcett JP, Seidah NG, Morris SJ, Sossin WS, Murphy RA (1999) Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J Neurosci 19:2069\u20132080","journal-title":"J Neurosci"},{"issue":"1","key":"9_CR501","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/EXNR.1997.6504","volume":"146","author":"EJ Mufson","year":"1997","unstructured":"Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU (1997) Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer\u2019s Disease. Exp Neurol 146(1):91\u2013103. https:\/\/doi.org\/10.1006\/EXNR.1997.6504","journal-title":"Exp Neurol"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1073\/pnas.92.11.5087","volume":"92","author":"T Mutoh","year":"1995","unstructured":"Mutoh T, Tokuda A, Miyadai T, Hamaguchi M, Fujiki N (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci U S A 92:5087\u20135091","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1126\/science.1411529","volume":"258","author":"RM Nitsch","year":"1992","unstructured":"Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304\u2013307","journal-title":"Science"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1073\/pnas.90.11.5191","volume":"90","author":"RM Nitsch","year":"1993","unstructured":"Nitsch RM, Farber SA, Growdon JH, Wurtman RJ (1993) Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc Natl Acad Sci U S A 90:5191\u20135193","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0006-8993(83)90046-X","volume":"289","author":"RC Pearson","year":"1983","unstructured":"Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK (1983) Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer\u2019s type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289:375\u2013379","journal-title":"Brain Res"},{"key":"9_CR82","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0002-9440(10)62275-4","volume":"166","author":"CE Pedraza","year":"2005","unstructured":"Pedraza CE, Podlesniy P, Vidal N, Arevalo JC, Lee R, Hempstead B, Ferrer I, Iglesias M, Espinet C (2005) Pro-NGF isolated from the human brain affected by Alzheimer\u2019s disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol 166:533\u2013543","journal-title":"Am J Pathol"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","volume":"93","author":"S Peng","year":"2005","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer\u2019s disease. J Neurochem 93:1412\u20131421","journal-title":"J Neurochem"},{"key":"9_CR84","unstructured":"Pentz R, Iulita MF, Juan Fortea A, Cuello C (2019) Identifying Alzheimer\u2019s disease in Down syndrome with NGF metabolism: hope for better treatment and diagnosis? T21RS Sci Soc Bull 1\u20133"},{"key":"9_CR503","doi-asserted-by":"publisher","unstructured":"Pentz R, Iulita MF, Ducatenzeiler A, Bennett DA, Cuello AC (2020) The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Mol Psychiatry:1\u201315. https:\/\/doi.org\/10.1038\/S41380-020-0797-2","DOI":"10.1038\/S41380-020-0797-2"},{"key":"9_CR85","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1471-4159.1995.65010347.x","volume":"65","author":"SJ Rabin","year":"1995","unstructured":"Rabin SJ, Mocchetti I (1995) GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA. J Neurochem 65:347\u2013354","journal-title":"J Neurochem"},{"key":"9_CR86","volume-title":"Degeneration & regeneration of the nervous system","author":"S Ram\u00f3n y Cajal","year":"1928","unstructured":"Ram\u00f3n y Cajal S, May RM (1928) Degeneration & regeneration of the nervous system. Oxford University Press, Humphrey Milford, London"},{"key":"9_CR87","unstructured":"Sabatini MT, Levi-Montalcini R, Angeletti PU (1966) [Early effects of anti-nerve growth factor serum on the nerve cell]. Ann Ist Super Sanita 2:349\u2013355"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","volume":"51","author":"A Salehi","year":"2006","unstructured":"Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC (2006) Increased App expression in a mouse model of Down\u2019s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51:29\u201342","journal-title":"Neuron"},{"issue":"6944","key":"9_CR89","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/bmj.308.6944.1638a","volume":"308","author":"J Samson","year":"1994","unstructured":"Samson J, Fiori MJB (1994) Gangliosides and the Guillain-Barre syndrome. BMJ Clin Res 308(6944):1638","journal-title":"BMJ Clin Res"},{"key":"9_CR90","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-8993(84)91338-6","volume":"300","author":"M Seiler","year":"1984","unstructured":"Seiler M, Schwab ME (1984) Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 300:33\u201339","journal-title":"Brain Res"},{"key":"9_CR91","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/0006-8993(83)90045-8","volume":"289","author":"MV Sofroniew","year":"1983","unstructured":"Sofroniew MV, Pearson RC, Eckenstein F, Cuello AC, Powell TP (1983) Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage. Brain Res 289:370\u2013374","journal-title":"Brain Res"},{"key":"9_CR92","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0006-8993(86)91503-9","volume":"398","author":"MV Sofroniew","year":"1986","unstructured":"Sofroniew MV, Pearson RC, Cuello AC, Tagari PC, Stephens PH (1986) Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrain. Brain Res 398:393\u2013396","journal-title":"Brain Res"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1126\/science.1688664","volume":"247","author":"MV Sofroniew","year":"1990","unstructured":"Sofroniew MV, Galletly NP, Isacson O, Svendsen CN (1990) Survival of adult basal forebrain cholinergic neurons after loss of target neurons. Science 247:338\u2013342","journal-title":"Science"},{"key":"9_CR94","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1471-4159.1985.tb05517.x","volume":"45","author":"PH Stephens","year":"1985","unstructured":"Stephens PH, Cuello AC, Sofroniew MV, Pearson RC, Tagari P (1985) Effect of unilateral decortication on choline acetyltransferase activity in the nucleus basalis and other areas of the rat brain. J Neurochem 45:1021\u20131026","journal-title":"J Neurochem"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0304-3940(87)90499-X","volume":"80","author":"PH Stephens","year":"1987","unstructured":"Stephens PH, Tagari PC, Garofalo L, Maysinger D, Piotte M, Cuello AC (1987) Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosides. Neurosci Lett 80:80\u201384","journal-title":"Neurosci Lett"},{"key":"9_CR96","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.me.39.020188.001205","volume":"39","author":"SS Stewart","year":"1988","unstructured":"Stewart SS, Appel SH (1988) Trophic factors in neurologic disease. Annu Rev Med 39:193\u2013201","journal-title":"Annu Rev Med"},{"key":"9_CR97","doi-asserted-by":"crossref","unstructured":"Svennerholm L (1980) Ganglioside designation. In: Structure and function of gangliosides. Springer","DOI":"10.1007\/978-1-4684-7844-0"},{"key":"9_CR98","first-page":"625","volume":"14","author":"G Tettamanti","year":"1988","unstructured":"Tettamanti G (1988) Towards the understanding of the physiological role of gangliosides. J New Trends Ganglioside Res Neurochem Neuroregenerative Aspects 14:625\u2013646","journal-title":"J New Trends Ganglioside Res Neurochem Neuroregenerative Aspects"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0306-4522(94)90285-2","volume":"59","author":"JL Venero","year":"1994","unstructured":"Venero JL, Knusel B, Beck KD, Hefti F (1994) Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration. Neuroscience 59:797\u2013815","journal-title":"Neuroscience"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"116576","DOI":"10.1016\/j.jns.2019.116576","volume":"408","author":"P Wanleenuwat","year":"2020","unstructured":"Wanleenuwat P, Iwanowski P, Kozubski W (2020) Antiganglioside antibodies in neurological diseases. J Neurol Sci 408:116576","journal-title":"J Neurol Sci"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237\u20131239","journal-title":"Science"},{"key":"9_CR102","doi-asserted-by":"publisher","first-page":"9231","DOI":"10.1073\/pnas.83.23.9231","volume":"83","author":"LR Williams","year":"1986","unstructured":"Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A 83:9231\u20139235","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR103","first-page":"224","volume":"135","author":"HM Wisniewski","year":"1988","unstructured":"Wisniewski HM, Wrzolek M (1988) Pathogenesis of amyloid formation in Alzheimer\u2019s disease, Down\u2019s syndrome and scrapie. Ciba Found Symp 135:224\u2013238","journal-title":"Ciba Found Symp"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(80)92137-6","volume":"2","author":"CM Yates","year":"1980","unstructured":"Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH (1980) Alzheimer-like cholinergic deficiency in Down syndrome. Lancet 2:979","journal-title":"Lancet"}],"container-title":["Advances in Experimental Medicine and Biology","Recent Advances in NGF and Related Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-74046-7_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T01:04:12Z","timestamp":1675645452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-74046-7_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030740450","9783030740467"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-74046-7_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"28 August 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"I would like to dedicate these reflections about trophic responses not only to the memory of Rita Levi Montalcini and her stellar career, but also as a tribute to Mario Bunge\u2019s legacy. He was one of the world\u2019s greatest philosophers of his generation. A philosopher with formal and deep knowledge of the physical and biological sciences. A philosopher who understood synaptic plasticity and who strongly made the case that mind, consciousness, and all psychological responses were strictly governed by neuronal connections and biochemical brain events. I had the privilege of sharing with Mario many interminable scientific discussions and with him and his family many memorable events. I will sorely miss his loss as a dear friend and as an inspiring McGill colleague.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dedication"}}]}}